Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/6/26 06:01 | 10/4/26 | PRE | Health | Drug | Pharmaceutical Preparations | Leogrande Hudson Blake | D | 3 | M.d | 0 | 0.00 | 0 | 6 | 300 | 8 | D | ||||||||||||||||
10/2/26 08:36 | 9/30/26 | PRE | Health | Drug | Pharmaceutical Preparations | Lo Hoi Chun | O | CFO | 2 | M.d | 0 | 0.00 | 0 | 86 | 18 | 574 | D | |||||||||||||||
8/26/26 08:23 | 8/24/26 | PRE | Health | Drug | Pharmaceutical Preparations | Rosin Brian J | O | CFO of I | 1 | P.m | 498 | 21.55 | 0 | 23 | 23 | D | ||||||||||||||||
8/24/26 21:41 | 8/20/26 | PRE | Health | Drug | Pharmaceutical Preparations | Yeung Danny Sheng Wu | DO | CEO | 2 | M.dm | 502 | 6.38 | 0 | 79 | 233 | 112 | D | |||||||||||||||
8/24/26 21:41 | 8/20/26 | PRE | Health | Drug | Pharmaceutical Preparations | Yeung Danny Sheng Wu | DO | CEO | 2 | P.dm | 502 | 6.38 | 0 | 79 | 233 | 112 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |